The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) has sided with the Broad Institute over the University of California (UC), the University of Vienna, and CRISPR pioneer and Nobel co-laureate Emmanuelle Charpentier, PhD, (collectively called CVC) in the bitter battle royal over who invented the gene-editing technology in eukaryotic cells.